Leukocytes: The Hidden Threats in Transfusion and the Lifesaving Role of Leukoreduction
Maxime Dely, Global Expert in Blood Processing & Therapeutic Apheresis, shared an insightful post on LinkedIn:
“Leukocytes: the invisible enemies of transfusion
I remember a patient we’ll call Laurent, 67 years old, who came in for a red blood cell transfusion due to severe anemia. Everything seemed under control… until two hours after the transfusion. Chills, sudden fever, blood pressure dropping.
On the surface, the blood unit looked perfect. Test results were normal. Yet an invisible culprit was there: leukocytes.
These white blood cells, vital allies in the donor’s body, can become real saboteurs in the recipient.
They can trigger:
- Febrile non-hemolytic transfusion reactions
- Alloimmunization that complicates future transfusions
- Unpredictable inflammatory reactions
This is where leukoreduction comes in: filtering the blood within hours after donation to remove more than 99.9% of these cells. A discreet step, but one that changes everything.
Since leukoreduction became standard practice in many transfusion systems, incidents like Laurent’s have become rare. But rare doesn’t mean impossible — and each case reminds us why this measure exists.
We’ve already discussed filtration in a previous article, but it’s important to remember that not all countries or organizations have the financial or equipments to access this technology.
In an upcoming article, we’ll see that centrifugation remains the first essential step toward leukoreduction, especially in settings with limited financial or material resources.
And you — do you think universal leukoreduction should be mandatory worldwide?”
Follow the newest insights in hematology with Hemostasis Today.
-
May 7, 2026, 17:56The Latest Clinical Data Shaping The Evolving Landscape of Hemophilia Treatment – EAHAD
-
May 7, 2026, 17:31Talha Badar: New Classical Hematology Chapter on Bleeding and Thrombosis
-
May 7, 2026, 17:26Maria Τektonidou: Gene Network Analysis Identifies STAT1 in Thrombotic APS
-
May 7, 2026, 17:23Sonu Bhaskar: Inflammatory Biomarkers in Acute Cerebral Venous Sinus Thrombosis
-
May 7, 2026, 16:53Patricio S. Espinosa: Anticoagulation Is Not an Absolute Contraindication to Amyloid Therapy
-
May 7, 2026, 16:34Arun V J: Give Blood and Be the Hero You Always Wanted to Be
-
May 7, 2026, 16:15August Bones: When Would You Consider Placing an Inferior Vena Cava Filter After a Pulmonary Embolism?
-
May 7, 2026, 15:58Stop Asking Doctors to Do More – Reimagining the Care Team – The US Oncology
-
May 7, 2026, 15:42Chokri Ben Lamine: CVC-Associated UE-DVT and Catheter Removal